Diagnostics: the growing arsenal of cardiac biomarkers: soluble neprilysin.

Discussion.

Medtronic International: CRT response optimisation with novel, non-invasive diagnostic technology.

Discussion.

Abbott Vascular: present & future of Abbott Vascular research in structural heart diseases.

Discussion.

scPharmaceuticals: furosemide 2.0: subcutaneous furosemide – a new tool for fluid management in heart failure.

Discussion.

HeartWare Inc : technology to proactively manage heart failure patients.

Discussion.